Umban, Angela .
HRN: 27-46-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/11/2025
07/25/2025
IV
4.5 Gram
Now
Sepsis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: